Credit Suisse’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $13.7M | Sell |
|
|||||
|
2023
Q4 | $13.2M | Buy |
|
|||||
|
2023
Q3 | $12.4M | Sell |
|
|||||
|
2023
Q2 | $11M | Sell |
|
|||||
|
2023
Q1 | $14.5M | Sell |
|
|||||
|
2022
Q4 | $53M | Sell |
|
|||||
|
2022
Q3 | $59.9M | Buy |
|
|||||
|
2022
Q2 | $51.8M | Buy |
|
|||||
|
2022
Q1 | $63.4M | Sell |
|
|||||
|
2021
Q4 | $54.8M | Sell |
|
|||||
|
2021
Q3 | $68.6M | Sell |
|
|||||
|
2021
Q2 | $71.7M | Buy |
|
|||||
|
2021
Q1 | $50.4M | Sell |
|
|||||
|
2020
Q4 | $67M | Sell |
|
|||||
|
2020
Q3 | $75.6M | Buy |
|
|||||
|
2020
Q2 | $98.9M | Sell |
|
|||||
|
2020
Q1 | $75M | Buy |
|
|||||
|
2019
Q4 | $67.1M | Sell |
|
|||||
|
2019
Q3 | $74.9M | Buy |
|
|||||
|
2019
Q2 | $66.2M | Buy |
|
|||||
|
2019
Q1 | $49.3M | Buy |
|
|||||
|
2018
Q4 | $23.4M | Sell |
|
|||||
|
2018
Q3 | $50.4M | Sell |
|
|||||
|
2018
Q2 | $81.2M | Buy |
|
|||||
|
2018
Q1 | $50.5M | Buy |
|
|||||
|
2017
Q4 | $46.5M | Buy |
|
|||||
|
2017
Q3 | $23.4M | Buy |
|
|||||
|
2017
Q2 | $38.1M | Buy |
|
|||||
|
2017
Q1 | $34.3M | Buy |
|
|||||
|
2016
Q4 | $37.3M | Buy |
|
|||||
|
2016
Q3 | $15.3M | Sell |
|
|||||
|
2016
Q2 | $36.3M | Buy |
|
|||||
|
2016
Q1 | $15.6M | Sell |
|
|||||
|
2015
Q4 | $45.2M | Sell |
|
|||||
|
2015
Q3 | $48.7M | Buy |
|
|||||
|
2015
Q2 | $42.7M | Sell |
|
|||||
|
2015
Q1 | $65.4M | Sell |
|
|||||
|
2014
Q4 | $67M | Sell |
|
|||||
|
2014
Q3 | $110M | Buy |
|
|||||
|
2014
Q2 | $84.3M | Buy |
|
|||||
|
2014
Q1 | $82.5M | Buy |
|
|||||
|
2013
Q4 | $41.7M | Buy |
|
|||||
|
2013
Q3 | $16.1M | Sell |
|
|||||
|
2013
Q2 | $30.6M | Buy |
|